Three types of bags are commonly used for IV fluids, which include glass bottles, PVC bags, and non-PVC bags. Certain drugs such as some insulin preservatives, vitamins, and others can react with PVC bags. Non-PVC bags are similar to PVC bags, but they generally do not react, although it depends on the drug being used. They are convenient for handling and transportation. The non-PVC IV bags include polypropylene IV bags, polyethylene IV bags, ethylene-vinyl acetate (EVA) IV bags, copolyester ether IV bags, and others.
The global non-PVC IV bags market is estimated to be valued at US$ 1,805.6 million in 2021, and is expected to exhibit a CAGR of 9.5% during the forecast period (2021-2028).
Figure 1. Global Non-PVC IV Bags Market Share (%) in Terms of Value, by Type, 2021
Increasing prevalence of cancer is expected to drive the market growth during the forecast period.
Factors such as the rising prevalence of cancer are expected to drive the market growth during the forecast period, as chemotherapy involves administration of medications orally or through an intravenous (IV) route. For instance, according to the World Health Organization (WHO), cancer is the second leading cause of death in the world. The American Cancer Society estimated that over 1.7 million new cancer cases were diagnosed in the U.S. in 2019. Moreover, according to an article published by Cancer Research U.K., in March 2020, 367,000 new cancer cases are reported each year in the U.K.
|Base Year:||2020||Market Size in 2021:||US$ 1,805.6 Mn|
|Historical Data for:||2017 to 2020||Forecast Period:||2021 to 2028|
|Forecast Period 2021 to 2028 CAGR:||9.5%||2028 Value Projection:||US$ 3,409.4 Mn|
Renolit SE, Kraton Corporation, Shanghai Solve Care Co., Ltd., Shanghai Xin Gen Eco-Technologies Co., Ltd., PolyCine GmbH, Jiangxi Sanxin Medtec Co., Ltd., Sealed Air, Baxter, B. Braun Melsungen AG, Sichuan Kelun Pharmaceutical Co., Ltd., Fresenius Kabi AG, Otsuka Holdings Co., Ltd., Sartorius AG, Technoflex, and Huaren Pharmaceutical Co., Ltd.
|Restraints & Challenges:||
Figure 2. Global Non-PVC IV Bags Market Share (%), by Material, 2021
Increasing product launches by the key players is expected to drive the market growth during the forecast period.
The increasing number of novel product launches by the key players is expected to drive the market growth during the forecast period. For instance, in April 2021, Fresenius Kabi, a global healthcare company, announced that it had introduced two new presentations of Heparin Sodium in ready-to-administer and convenient Freeflex IV bags in the U.S. Freeflex bags are made up of polyolefin, which are Di-ethylhexyl-phthalate (DEHP) plasticizer free and non PVC.
Global Non-PVC IV Bags Market– Impact of Coronavirus (COVID-19) Pandemic
Before COVID-19, the healthcare industry was shifting towards community wellness and population health while still economically dependent on expensive, invasive procedures, and treatments. Key players conducted their operations smoothly and were focused on implementing growth strategies such as product approval and acquisition in the global non-PVC IV bags market.
Due to COVID-19, lockdown or shutdown was imposed in several countries globally, which had a negative impact on the economy of the private healthcare sector globally. Furthermore, healthcare providers were facing challenges, in terms of additional manpower, equipment, consumables, and other resources, which are required to ensure safety in hospitals and provide treatment to patients with other diseases, and this has impacted the market negatively. Due to nationwide lockdowns, the supply chain was badly hampered. This caused problems in the transportation of non-PVC IV bags from one place to another.
Global Non-PVC IV Bags Market: Restraint
The major factor that hinder growth of the global non-PVC IV bags market include high cost of the non-PVC IV bags and stringent government regulatory policies.
Major players operating in the global non-PVC IV bags market include Renolit SE, Kraton Corporation, Shanghai Solve Care Co., Ltd., Shanghai Xin Gen Eco-Technologies Co., Ltd., PolyCine GmbH, Jiangxi Sanxin Medtec Co., Ltd., Sealed Air, Baxter, B. Braun Melsungen AG, Sichuan Kelun Pharmaceutical Co., Ltd., Fresenius Kabi AG, Otsuka Holdings Co., Ltd., Sartorius AG, Technoflex, and Huaren Pharmaceutical Co., Ltd.
An intravenous bag is used to hold fluids and is a sterile bag made of either thick plastic or glass bottles. During intravenous therapy, the fluid from the IV bag is administered to the patient intravenously. The fluid in the bag consists of blood in case of a blood transfusion, mixtures of medicines, or saline for hydration. Commonly, the IV bags are made of polyvinyl chloride (PVC) or other plastic material. However, some manufacturers offer non-PVC IV bags due to the advantages offered by them, such as less contamination from the chemicals used in the preparation of vinyl. Rising awareness regarding the use of non-PVC IV bags and increasing government initiatives will drive the growth of non-PVC IV bags market over the forecast period.
Key players in the market are focusing on product launches and approvals in order to enhance their market presence. For instance, in December 2020, Fresenius Kabi, a global healthcare company, announced the launch of acetaminophen injection in free flex containers for the U.S. market. Freeflex bags are delivery systems that are non-PVC, clear, non-DEHP and made without the use of natural rubber latex. Freeflex bags minimize drug errors and maximize patient safety. They additionally feature leak-resistant technology and sterile ports along with tamper-evident breakoff caps that can help reduce the risk of contamination.
Moreover, in January 2018, Baxter, a U.S. based multinational health care company, announced that it had received the U.S. regulators' approval to import large IV saline bags from its plant in Mexico. The effort was initiated to ease hospital shortages of the product as a severe flu season was faced by the U.S.
Key features of the study:
“*” marked represents similar segmentation in other categories in the respective section.